Search results for: NHS Expenditure
Filter search results
Prevention pays off – so why aren’t we doing more of it?
5 June 2025
…in the UK, for example, the NHS still functions largely as a “sick care” system, treating illness rather than valuing prevention as an investment. Short-term thinking: annual funding cycles make…
New OHE research finds productivity losses from respiratory infections cost UK businesses £44 billion per year
16 December 2024
…high prevalence of respiratory infections — concentrated over the winter months — they have a direct and considerable impact on both the NHS as well as businesses and the economy at large….
Valuing Health at the End of Life: A Stated Preference Discrete Choice Experiment
1 December 2012
…Appraisal Committees are to consider when assessing treatments that extend life at the end of life. This includes an option for approving such treatments for use in the NHS if…
Valuing Health at the End of Life: An Exploratory Preference Elicitation Study
1 December 2011
…Appraisal Committees are to consider when assessing treatments that extend life at the end of life. This includes an option for approving such treatments for use in the NHS if…
Willingness to Pay and Publicly Funded Health Care: Contradiction in Terms?
1 November 2011
…benefits, through elicitation of patients’ and the public’s willingness to pay, are not only useful, buy feasible and defensible in a system such as the NHS, which is funded largely…
Childhood Vaccination: Current Controversies
1 July 1984
…diseases is one of the most obvious failures of the NHS’. This paper investigates the purported deficiencies of vaccination policies in Britain as they relate to measles, rubella and whooping…
Obesity
1 July 1994
…issue of prevention of obesity; chapter seven assesses social attitudes towards obesity; chapter eight sets out the cost to the NHS of treating obesity and chapter nine gives the conclusion….
Deep Vein Thrombosis and Pulmonary Embolism
10 January 1996
…exist to both treat and prevent deep vein thrombosis and their relative cost effectiveness using published economic evaluations; • looks at the cost to the NHS of deep vein thrombosis…
Multi-indication Pricing: Pros, Cons and Applicability to the UK
1 October 2015
…challenge of providing optimal pricing for, and reimbursement of, multi-indication drugs and (ii) the feasibility of implementing MIP in the UK’s National Health Service (NHS). The workshop agreed that relative…